readthroughSign in
CompanyCTMXNasdaqSouth San Francisco, CA

CytomX Therapeutics

CytomX Therapeutics develops conditionally activated biologics using its PROBODY platform, which masks therapeutic binding until tumor proteases remove the mask, enabling selective tumor targeting in oncology.

424B3Nov 12Latest SEC filing
Nov 3Latest story